Noxopharm advances lupus therapy with data pointing to durable skin targeting and low systemic exposure

The company has been examining in greater detail how often the treatment may need to be administered, with a focus on identifying an optimal dosing regimen as it prepares the next stage of clinical development and regulatory engagement. …